Rupert Vessey
Fortuna: 776 232 $ al 30/06/2026
Fortuna: 776 232 $ al 30/06/2026
Rupert J. Vessey ocupa el cargo de Vicepresidente Ejecutivo de Investigación y Desarrollo Temprano en Bristol Myers Squibb Co. También forma parte del consejo de administración de Bio-Techne Corp, PharmAkea, Inc, Sidecar Therapeutics, Inc y Elstar Therapeutics, Inc y es miembro del Real Colegio de Médicos. En el pasado, Rupert J. Vessey ocupó el cargo de Vicepresidente Senior de Desarrollo Temprano y Ciencias del Descubrimiento en Merck & Co., Inc. y Presidente de Investigación y Desarrollo Temprano en Celgene Corp. El Dr. Vessey se graduó, se doctoró y se licenció en la Universidad de Oxford.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIO-TECHNE CORPORATION 0,01 % | 30/10/2025 | 10.987 ( 0,01 % ) | 776 232 $ | 30/06/2026 |
| 27/02/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIO-TECHNE CORPORATION | Director/Miembro de la Junta | 26/06/2019 |
| GENERATE BIOMEDICINES, INC. | Director/Miembro de la Junta | 01/06/2024 |
PharmAkea, Inc.
PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drug candidates against protein targets involved in fibroproliferative diseases | Director/Miembro de la Junta | - |
Sidecar Therapeutics, Inc.
Sidecar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Miembro de la Junta | - |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Director/Miembro de la Junta | 01/08/2018 |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio-molecular condensate drug discovery and development company | Director/Miembro de la Junta | 25/10/2021 |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Inversor de Capital Privado | 01/07/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Director Técnico/Científico/I+D | 03/07/2023 |
| ░░░░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 14 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Bio-Techne Corp.
Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
PharmAkea, Inc.
PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drug candidates against protein targets involved in fibroproliferative diseases | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Sidecar Therapeutics, Inc.
Sidecar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies for cancer treatment | Health Technology |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Operates as a bio-molecular condensate drug discovery and development company | Health Technology |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.